Consolidated income statement
x € million |
|
Notes |
|
2022 |
|
2021 |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
Continuing operations |
|
|
|
|
|
|
Net sales |
|
|
8,390 |
|
7,269 |
|
Cost of sales |
|
|
(5,700) |
|
(4,657) |
|
Gross margin |
|
|
|
2,690 |
|
2,612 |
|
|
|
|
|
|
|
Marketing and sales |
|
|
(1,235) |
|
(1,172) |
|
Research and development |
|
|
(295) |
|
(274) |
|
General and administrative |
|
|
(534) |
|
(475) |
|
Other operating income |
|
|
107 |
|
82 |
|
Other operating expense |
|
|
(51) |
|
(62) |
|
Operating profit |
|
|
|
682 |
|
711 |
|
|
|
|
|
|
|
Financial income |
|
|
71 |
|
24 |
|
Financial expense |
|
|
(159) |
|
(124) |
|
Profit before income tax expense |
|
|
|
594 |
|
611 |
|
|
|
|
|
|
|
Income tax expense |
|
|
(124) |
|
(123) |
|
Share of the profit of associates and joint ventures |
|
|
12 |
|
16 |
|
Other results related to associates and joint ventures |
|
|
(7) |
|
326 |
|
|
|
|
|
|
|
|
Net profit from continuing operations |
|
|
|
475 |
|
830 |
Net profit from discontinued operations |
|
|
1,240 |
|
850 |
|
Net profit for the year |
|
|
|
1,715 |
|
1,680 |
|
|
|
|
|
|
|
Of which: |
|
|
|
|
|
|
- Attributable to non-controlling interests |
|
|
15 |
|
4 |
|
- Dividend on Cumulative Preference Shares |
|
|
6 |
|
6 |
|
- Available to holders of ordinary shares |
|
|
1,694 |
|
1,670 |
|
|
|
|
|
|
|
|
Earnings per share (EPS) total (in €): |
|
|
|
|
|
|
- Net basic EPS |
|
|
|
9.80 |
|
9.68 |
- Net diluted EPS |
|
|
|
9.77 |
|
9.63 |
|
|
|
|
|
|
|
Earnings per share (EPS) continuing operations (in €): |
|
|
|
|
|
|
- Net basic EPS |
|
|
|
2.64 |
|
4.76 |
- Net diluted EPS |
|
|
|
2.63 |
|
4.74 |
The accompanying notes are an integral part of these consolidated financial statements.
See Note 2 Alternative performance measures for the reconciliation to Adjusted EBITDA of €1,395 million (2021: €1,379 million) and other adjusted IFRS performance measures.
